Radnostix INIS
OTC INIS
$0.04 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Radnostix (INIS) Convertible Debt (2012 - 2013)

Updated

Radnostix's Convertible Debt was $2.71 million in FY2012.

Analysis

Radnostix (INIS) Convertible Debt (2012 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Radnostix 20.37 Mn 14.48 Mn 1.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 3.72 Mn
Dec 31, 2012 2.71 Mn
Sep 30, 2012 2.69 Mn
API Access

Radnostix Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=INIS&period=max&api_key=YOUR_API_KEY